middle.news
University of Virginia Joins Imricor’s VISABL-AFL Trial as Second US Site
8:35am on Monday 15th of December, 2025 AEDT
•
Healthcare
Read Story
University of Virginia Joins Imricor’s VISABL-AFL Trial as Second US Site
8:35am on Monday 15th of December, 2025 AEDT
Key Points
University of Virginia Health approved as second US VISABL-AFL trial site
Site initiation completed; contract finalisation and training planned for January 2026
Clinical procedures expected to start in February 2026
Supports Imricor’s MRI-guided cardiac ablation technology development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imricor Medical Systems (ASX:IMR)
OPEN ARTICLE